Adaptimmune Therapeutics plc
Adaptimmune Therapeutics plc (ADAP) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · ADAP · as of Jun 8, 2026
Key Statistics
Explore Adaptimmune Therapeutics plc Data
adap stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 16 · Buy rate: 56.3%
The ADAP analyst consensus is Buy, based on ratings from 16 Wall Street analysts over the past 3 months. The average 12-month price target is $2.83, representing +5735.05% upside from the current price of $0.05.
Competitors & Peers
adap competitorsADAP
ANL
APLM
BLRX
ERNA
GOVXStock Performance
Full HistoryAbout Adaptimmune Therapeutics plc
Adaptimmune Therapeutics plc is a clinical-stage biopharmaceutical company dedicated to developing innovative cell therapies. Its primary focus is on addressing solid tumors in patients across the Uni…
what is adaptimmune therapeutics plc · adap stock overview · adaptimmune therapeutics plc company profile · who is adaptimmune therapeutics plc ceo · adap NASDAQ · adaptimmune therapeutics plc headquarters · adaptimmune therapeutics plc business segments
About Stock Overview & Key Data
Adaptimmune Therapeutics plc (ADAP) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since May 6, 2015. As of the latest trading session, ADAP stock price is $0.05, with a market capitalization of $75.2M. The stock has returned -91.75% over the past 12 months and -92.22% year-to-date.
According to 16 Wall Street analysts, the consensus rating for Adaptimmune Therapeutics plc stock is Buy, with an average 12-month price target of $2.83. In fiscal year 2024, Adaptimmune Therapeutics plc reported revenue of $178.0M and net income of -$70.8M. For detailed data — including Adaptimmune Therapeutics plc revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Adaptimmune Therapeutics plc (ADAP) stock price is $0.05. The stock is traded on NASDAQ under the ticker symbol ADAP. The 52-week range is $0.02 – $0.86.